We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$569M
AUM Growth
+$16.2M
Cap. Flow
+$9.27M
Cap. Flow %
1.63%
Top 10 Hldgs %
38.04%
Holding
152
New
24
Increased
39
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$7.05M
2
LITE icon
Lumentum
LITE
+$4.46M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.21M
4
GLW icon
Corning
GLW
+$4.19M
5
ADM icon
Archer Daniels Midland
ADM
+$4.08M

Top Sells

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$5.19M
2
MRK icon
Merck
MRK
+$4.37M
3
HAL icon
Halliburton
HAL
+$4.06M
4
CNDT icon
Conduent
CNDT
+$3.42M
5
MSFT icon
Microsoft
MSFT
+$3.37M

Sector Composition

Rank Sector Weight
1 Industrials 26.14%
2 Healthcare 24.39%
3 Technology 16.99%
4 Miscellaneous 8.59%
5 Utilities 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$39.3M 6.91%
588,788
+14,168
+2% +$949K
XOM icon
2
ExxonMobil
XOM
$644B
$32.6M 5.73%
425,473
+28,363
+7% +$2.2M
GVA icon
3
Granite Construction
GVA
$5.44B
$27.9M 4.91%
579,325
+60,600
+12% +$2.65M
GLW icon
4
Corning
GLW
$128B
$26M 4.57%
782,510
+130,628
+20% +$4.19M
PFE icon
5
Pfizer
PFE
$159B
$18.9M 3.32%
459,342
-3,235
-0.7% -$128K
BMY icon
6
Bristol-Myers Squibb
BMY
$136B
$16.2M 2.86%
358,268
+90,311
+34% +$4.21M
INTC icon
7
Intel
INTC
$473B
$14.7M 2.59%
307,726
-3,277
-1% -$162K
NVS icon
8
Novartis
NVS
$292B
$14.5M 2.55%
158,800
-19,063
-11% -$1.61M
JNJ icon
9
Johnson & Johnson
JNJ
$646B
$13.3M 2.33%
95,205
-847
-0.9% -$117K
XRAY icon
10
Dentsply Sirona
XRAY
$2.22B
$12.9M 2.26%
220,600
-3,075
-1% -$165K
GSK icon
11
GSK
GSK
$102B
$12.5M 2.19%
248,980
+51,780
+26% +$2.6M
OGE icon
12
OGE Energy
OGE
$9.45B
$12.4M 2.17%
290,543
-3,160
-1% -$134K
EEMV icon
13
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
$12.3M 2.16%
208,839
-3,350
-2% -$196K
FLS icon
14
Flowserve
FLS
$10.2B
$12.3M 2.16%
233,285
-2,650
-1% -$130K
BCE icon
15
BCE
BCE
$21.9B
$10.7M 1.88%
235,494
-3,000
-1% -$135K
LGTY
16
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$10.3M 1.81%
780,901
-13,150
-2% -$173K
MDU icon
17
MDU Resources
MDU
$4.16B
$10.2M 1.8%
1,040,464
+5,681
+0.5% +$55.3K
LNN icon
18
Lindsay Corp
LNN
$1.16B
$9.9M 1.74%
120,398
+5,525
+5% +$462K
MSFT icon
19
Microsoft
MSFT
$3.81T
$9.4M 1.65%
70,198
-26,571
-27% -$3.37M
EVRG icon
20
Evergy
EVRG
$18.6B
$9.16M 1.61%
152,238
-4,942
-3% -$289K
BNS icon
21
Scotiabank
BNS
$113B
$8.53M 1.5%
156,850
+26,550
+20% +$1.42M
HON icon
22
Honeywell
HON
$68.9B
$8.52M 1.5%
51,758
-233
-0.4% -$37.1K
TEL icon
23
TE Connectivity
TEL
$58.7B
$7.58M 1.33%
79,150
-500
-0.6% -$45.1K
ABT icon
24
Abbott
ABT
$195B
$7.57M 1.33%
89,984
-39,938
-31% -$3.14M
WTS icon
25
Watts Water Technologies
WTS
$12.2B
$7.51M 1.32%
80,582
-29,860
-27% -$2.55M

Similar funds

John G. Ullman & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, John G. Ullman & Associates held 152 positions worth $569M, up 2.9% from $552M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

John G. Ullman & Associates's Q2 2019 filing shows 24 new, 39 increased, 63 reduced and 4 closed positions. Its largest new stake was DXC Technology: 45,400 shares worth $2.5M. The largest sale was Trane Technologies, an estimated $5.19M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

  • John G. Ullman & Associates's largest Q2 2019 buy was DXC Technology: 45,400 shares worth $2.5M.
  • John G. Ullman & Associates added most to 3M in Q2 2019, an estimated $7.05M increase.
  • John G. Ullman & Associates's biggest Q2 2019 reduction was Trane Technologies, cutting an estimated $5.19M.
  • John G. Ullman & Associates fully exited Kinder Morgan in Q2 2019, selling an estimated $2.48M.
  • John G. Ullman & Associates's ten largest holdings make up 38% of its $569M portfolio in Q2 2019.
  • John G. Ullman & Associates opened 24 new positions and closed 4 in Q2 2019.
  • John G. Ullman & Associates's portfolio value rose 2.9% quarter-over-quarter to $569M.

Based on John G. Ullman & Associates's 13F filing for Q2 2019, filed 2 Aug 2019.